FaithAnchor

$Food Empire(F03.SG)

Food Empire: Headline Risk or Fundamental Warning?

Food Empire (SGX: F03) fell about 10% after Russia placed Nestlé’s local assets under temporary administration. The selloff was not caused by any action against Food Empire. Instead, investors repriced the possibility that Russian authorities could eventually target other foreign businesses.

The concern is legitimate. Russia contributed about US$191 million, or 33% of FY2025 revenue, while Russian revenue continued growing in FY2026. That creates meaningful geopolitical concentration.

Yet the fundamentals remain resilient. 1H2026 revenue rose 15% to US$315.1 million, while normalised net profit increased 12.2% to US$35.3 million. Growth is also supported by markets outside Russia.

At around S$1.92, Food Empire trades at roughly 13x forward earnings with a dividend yield near 5.7%. Technically, however, momentum remains weak: the stock is below its 50-day and 200-day moving averages, while RSI is around 30, indicating heavily oversold conditions.

The key warning investors should not dismiss is the Russia stress test. If Russian operations were completely removed, FY2027 net profit could fall almost 30%, from about US$83.7 million to US$58.9 million. That would be a genuine earnings shock, not merely headline noise.

For now, Food Empire has indicated that its Russian operations remain normal. The current drawdown therefore looks more headline-driven than fundamentally driven. But investors should not assume the risk disappears.

Mitigation is straightforward: avoid excessive portfolio concentration, diversify geographically, and monitor any Russian regulatory action involving Food Empire’s assets or operations.

The investment thesis changes materially if temporary administration, asset seizure or restrictions are imposed directly on Food Empire.

The takeaway: the selloff may fade, but Russia remains a risk that deserves a valuation discount and disciplined position sizing.

$Nike(NKE.US)

Nike: The Turnaround Is Losing Momentum

Nike’s decline is starting to look less like a normal cyclical slowdown and more like a brand problem.

FY2026 revenue was roughly flat at US$46.4 billion, while net income fell 3% to US$3.1 billion. More worrying, Nike Direct revenue dropped 7%. China remains a major drag, with Greater China sales declining for nine consecutive quarters.

The brand is also losing cultural relevance. Kylian Mbappé, one of football’s biggest names, has moved from Nike to On. Losing a global ambassador of that calibre matters because Nike’s competitive advantage has always been more than shoes — it is culture, athletes and brand heat.

Elliott Hill has been cutting costs, simplifying the business and pushing product innovation. But another US$2.5 billion restructuring programme and further job cuts raise the question: is Nike treating the symptoms rather than fixing the underlying problem?

At around US$35, the stock trades at roughly 17x earnings, but that multiple is difficult to call cheap when revenue is still falling. Technically, the shares remain below key moving averages and close to the 52-week low, with RSI around 37.

For shareholders already assigned shares, repeatedly selling covered calls may not be ideal when the stock is depressed. A collar strategy could be worth considering: sell an out-of-the-money call and use the premium to partially fund a protective put. This limits downside while leaving room for a recovery.

Nike doesn’t simply need to cut costs. It needs consumers to want Nike again.

$DBS(D05.SG)

Singapore Banks: Is the Pullback a Buying Opportunity?

DBS, OCBC and UOB have taken a hit, falling around 6%, 10% and 8% respectively between 6 and 8 October. After years of strong gains, the sell-off raises a familiar question: is it time to buy the dip, or is more pain ahead?

The biggest concern is rising global bond yields. If yields remain elevated, bank valuations could face further pressure, even if earnings hold up. With 3Q26 results around the corner, investors will be watching net interest margins, wealth management fees, funding costs and credit quality. Expectations are already high, particularly for DBS and OCBC, leaving less room for disappointment.

Which bank deserves a closer look? DBS remains attractive for investors seeking dividends and exposure to wealth management. OCBC offers a more diversified mix through banking, insurance and wealth management, while UOB could appeal to investors looking for value after its recent decline. However, none is automatically cheap simply because its share price has fallen.

For investors sitting on cash, there is no need to go all in. Consider deploying around 25–30% of the intended investment first, keeping the balance for further weakness or a more attractive entry after earnings. Those who missed the initial pullback should resist chasing a rebound.

Existing shareholders should focus on whether the investment case has changed, rather than reacting to short-term price movements.

The bottom line: Singapore banks may be entering a more attractive buying zone, but the correction may not be over. Staggering purchases, checking valuations and keeping some cash in reserve could be a more sensible approach than trying to call the bottom.

The opportunity is there, but patience and price discipline will matter. Not financial advice.

$Cent Accom REIT(8C8U.SG)

8C8U: Adelaide Expansion — Growth Opportunity or Gearing Risk?

Centurion’s proposed S$22.3 million Adelaide land acquisition could open another growth avenue through purpose-built student accommodation. But for 8C8U investors, the real question is whether expansion will translate into higher distributions or simply more debt.

CAREIT’s 1H2026 fundamentals look encouraging, with 98.8% PBSA occupancy, a 72% NPI margin and aggregate leverage of 29.9%. Yet the Adelaide project is not automatically dividend-accretive to 8C8U, as the acquisition sits with its parent, Centurion Corporation.

Technically, the unit price is trading below its 50-day and 200-day moving averages, suggesting near-term weakness despite resilient operating performance.

My take: the long-term opportunity is promising, but investors should watch funding costs, gearing and DPU growth before pricing in the Adelaide expansion. Growth is welcome — provided it delivers returns rather than just a bigger balance sheet.

Not financial advice.